Biotech startup Vivodyne is planning to revolutionize drug development with an AI-powered robot that can grow, dose, and analyze...

Vivodyne announced the close of $38 million in total seed financing, led by Khosla Ventures, with participation from Kairos...

Vivodyne announced today that it has expanded its executive team with Dr. Susan Billings joining as its Chief Commercial...

The U.S. Senate unanimously passed the FDA Modernization Act 2.0, S.5002 on September 28. As we shared last month,...

Dr. Jane Goodall and Vivodyne announced that they have delivered a letter to Congress urging its inclusion of the...

Vivodyne has been named #1 in the list of Fast Company’s World’s Most Innovative “Small but Mighty” Companies for 2022. This...

Vivodyne's goal is to lower the bar for labs and scientists to test their own research. This Penn-founded biotech...

Vivodyne, a startup developing a new bio-pharma discovery pipeline that starts and ends in lab-grown human tissues, announced today...